Literature DB >> 23704356

The Aurora-B-mediated phosphorylation of SHCBP1 regulates cytokinetic furrow ingression.

Eri Asano1, Hitoki Hasegawa, Toshinori Hyodo, Satoko Ito, Masao Maeda, Masahide Takahashi, Michinari Hamaguchi, Takeshi Senga.   

Abstract

Centralspindlin, which is composed of MgcRacGAP and MKLP1, is essential for central spindle formation and cytokinetic furrow ingression. MgcRacGAP utilizes its GAP domain to inactivate Rac1 and induce furrow ingression in mammalian cells. In this report, we present a novel regulatory mechanism for furrowing that is mediated by the phosphorylation of SHC SH2-domain binding protein 1 (SHCBP1), a binding partner of centralspindlin, by Aurora B (AurB). AurB phosphorylates Ser634 of SHCBP1 during mitosis. We generated a phosphorylation site mutant, S634A-SHCBP1, which was prematurely recruited to the central spindle during anaphase and inhibited furrowing. An in vitro GAP assay demonstrated that SHCBP1 can suppress the MgcRacGAP-mediated inactivation of Rac1. In addition, the inhibition of Rac1 activity rescued the furrowing defect induced by S634A-SHCBP1 expression. Thus, AurB phosphorylates SHCBP1 to prevent the premature localization of SHCBP1 to the central spindle and ensures that MgcRacGAP inactivates Rac1 to promote the ingression of the cytokinetic furrow.

Entities:  

Keywords:  Aurora B; Central spindle; Centralspindlin; Cytokinesis; SHCBP1

Mesh:

Substances:

Year:  2013        PMID: 23704356     DOI: 10.1242/jcs.124875

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  18 in total

1.  SHCBP1 is required for midbody organization and cytokinesis completion.

Authors:  Eri Asano; Hitoki Hasegawa; Toshinori Hyodo; Satoko Ito; Masao Maeda; Dan Chen; Masahide Takahashi; Michinari Hamaguchi; Takeshi Senga
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

2.  FGF13 interaction with SHCBP1 activates AKT-GSK3α/β signaling and promotes the proliferation of A549 cells.

Authors:  Hongzhao Lu; Meichen Yin; Ling Wang; Jia Cheng; Wei Cheng; Huanping An; Tao Zhang
Journal:  Cancer Biol Ther       Date:  2020-10-16       Impact factor: 4.742

3.  Gene expression profiling and in vitro functional studies reveal RAD54L as a potential therapeutic target in multiple myeloma.

Authors:  Ivyna Pau Ni Bong; Ching Ching Ng; Norodiyah Othman; Ezalia Esa
Journal:  Genes Genomics       Date:  2022-06-11       Impact factor: 2.164

Review 4.  Controlling the switches: Rho GTPase regulation during animal cell mitosis.

Authors:  Yan Zuo; Wonkyung Oh; Jeffrey A Frost
Journal:  Cell Signal       Date:  2014-10-05       Impact factor: 4.315

5.  Hyperactivation of HER2-SHCBP1-PLK1 axis promotes tumor cell mitosis and impairs trastuzumab sensitivity to gastric cancer.

Authors:  Wengui Shi; Gengyuan Zhang; Zhijian Ma; Lianshun Li; Miaomiao Liu; Long Qin; Zeyuan Yu; Lei Zhao; Yang Liu; Xue Zhang; Junjie Qin; Huili Ye; Xiangyan Jiang; Huinian Zhou; Hui Sun; Zuoyi Jiao
Journal:  Nat Commun       Date:  2021-05-14       Impact factor: 14.919

6.  Unexpected phenotype of mice lacking Shcbp1, a protein induced during T cell proliferation.

Authors:  Monica W Buckley; Sanja Arandjelovic; Paul C Trampont; Taeg S Kim; Thomas J Braciale; Kodi S Ravichandran
Journal:  PLoS One       Date:  2014-08-25       Impact factor: 3.240

7.  Chromosomal instability induced by increased BIRC5/Survivin levels affects tumorigenicity of glioma cells.

Authors:  Marina Conde; Susanne Michen; Ralf Wiedemuth; Barbara Klink; Evelin Schröck; Gabriele Schackert; Achim Temme
Journal:  BMC Cancer       Date:  2017-12-28       Impact factor: 4.430

8.  Temporal proteomic analysis of HIV infection reveals remodelling of the host phosphoproteome by lentiviral Vif variants.

Authors:  Edward Jd Greenwood; Nicholas J Matheson; Kim Wals; Dick Jh van den Boomen; Robin Antrobus; James C Williamson; Paul J Lehner
Journal:  Elife       Date:  2016-09-30       Impact factor: 8.140

9.  SHCBP1 promotes synovial sarcoma cell metastasis via targeting TGF-β1/Smad signaling pathway and is associated with poor prognosis.

Authors:  Changliang Peng; Hui Zhao; Yan Song; Wei Chen; Xiaoying Wang; Xiaoli Liu; Cheng Zhang; Jie Zhao; Ji Li; Guanghui Cheng; Dongjin Wu; Chunzheng Gao; Xiuwen Wang
Journal:  J Exp Clin Cancer Res       Date:  2017-10-11

10.  Identification of SHCBP1 as a novel downstream target gene of SS18-SSX1 and its functional analysis in progression of synovial sarcoma.

Authors:  Changliang Peng; Hui Zhao; Wei Chen; Yan Song; Xiaoying Wang; Ji Li; Yong Qiao; Dongjin Wu; Shengzhong Ma; Xiuwen Wang; Chunzheng Gao
Journal:  Oncotarget       Date:  2016-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.